Kuljit Singh, Shailesh Sharma
Kuljit Singh1*, Shailesh Sharma2
1Resarch Scholar, IKG Punjab Technical University, Jalandhar-Kapurthala Highway, Kapurthala Punjab. India 144 603.
2Pharmaceutical Research Division, Department of Pharmaceutics, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, BELA (Ropar) Punjab India 140 111
Volume - 14,
Issue - 2,
Year - 2021
The oral delivery of drugs undergoing extensive first-pass metabolism is a tedious task, as the bioavailability of such agents is severely hampered, resulting in poor pharmacological response and compromised dose economics. Cardiovascular diseases are a leading cause of mortality and morbidity all over the globe, wherein nifedipine is such a prescribed drug with extensive first-pass metabolism and compromised bioavailability. In an attempt to alleviate the concerns of nifedipine employing simple materials and methods, orodispersible tablets (ODTs) of nifedipine were explored using various methods and materials. Out of various methods viz. lyophilization technique, wet granulation, dry granulation and cotton-candy process, the last method fetched with ODTs with acceptable disintegration time, wetting time and drug release profile over 10 minutes in Sorenson’s buffer simulating saliva. The novel material used Calcium Cross-Linked Cassia Fistula gum offered substantially improved ODT product over the conventional material, i.e., Croscarmellose Sodium (CCS). The optimized ODT not only improved the bioavailability of the drug by decreasing the drug extraction at the liver site, as evident from in-vivo pharmacokinetic studies, but also offered substantial reduction in the systolic blood pressure in L-NAME antihypertensive studies in Wistar rats. The in-vivo performance of the selected ODT was far more improved than that the available marketed product as well as the plain drug, advocating the superiority of the developed system over the marketed one. The pharmacokinetic, biodistribution and pharmacological evidences coupled with the results from the in-vitro parameters like wetting time, disintegration time and drug release profile provide a ray of hope for a commercially viable ODT product for nifedipine to manage the hypertension related problems.
Cite this article:
Kuljit Singh, Shailesh Sharma. Development of Nifedipine Orodispersible Tablets by different techniques using natural and synthetic superdisintegrants. doi: 10.5958/0974-360X.2021.00125.6
1. Joseph A. Pharmaceutical dosage forms and drug delivery systems. Journal of Pharmaceutical Sciences. 1990; 79 (11):1044.
2. Tejas K, Ganesh D.A Review on Orodispersible Tablets: A Novel Approach. Research Journal of Pharmacy and Technology.2019; 12(8): 3993-4001.
3. Jaybhaye A, Joshi S, Deshmukh G. Orodispersible Tablets: A Comprehensive Review. Research Journal of Pharmacy and Technology.2014; 7(3): 368-375.
4. Srinivasa S., Narayana RC, Satyanarayana D S, Srilakshmi D. Formulation and Evaluation of Orodispersible Tablets of an Antiulcer Agent. Research Journal of Pharmacy and Technology. 2017; 10(3): 747-750.
5. Barich DH, Zell MT, Munson EJ. Physicochemical Properties, formulation, and drug delivery.Wiley Online Library.https:// doi.org/10.1002/9781118833322.ch3
6. Hannan PA, Khan JA, Khan A, Safiullah S. Oral dispersible system: A new approach in drug delivery system. Indian Journal of Pharmaceutical Sciences. 2016;78 (1): 2–7.
7. Pade V, Stavchansky S. Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model. Pharm. Research. 1997; 14 (9):1210–1215.
8. Rai PR, Tiwary AK., Rana V. Superior disintegrating properties of calcium cross-linked Cassia fistula gum derivatives for fast dissolving tablets. Carbohydrate Polymer. 2012a ;87 (2):1098–1104.
9. Leucuţa SE, Vida-Simiti L, Căprioară MG, Făgărăşan E, Olinic N, Manasia M, Vlaicu R. Bioavailability of nifedipine from different oral dosage forms in healthy volunteers. Die Pharmazie .1989;44 (5): 336–338.
10. Killedar SG, Nale AB, More HN, Nadaf SJ, Pawar AA, Tamboli US. Isolation, characterization, and evaluation of Cassia fistula Linn. seed and pulp polymer for pharmaceutical application. International. Journal of Pharmaceutical Investigation. 2014; 4 (4): 215–225.
11. Singh SK., Singh S. Evaluation of cassia fistula linn. Seed Mucilage in tablet formulations. International Journal of PharmTech Research. 2010;2 (3): 1839-1846
12. Goyal P, Kumar V, Sharma P. 2007. Carbohydrate polymers., Carbohydrate polymers. Elsevier Science Pub. Co.
13. Dave V, Yadav RB, Ahuja R, Yadav S. Formulation design and optimization of novel fast dissolving tablet of chlorpheniramine maleate by using lyophilization techniques. Bulletin of Faculty of Pharmacy. 2017;55:31–39.
14. Shoukri R, Ahmed IS, Shamma RN . In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. European Journal of Pharmaceutics and Biopharmaceutics.2009; 73 (1): 162–171.
15. Gerald E Battist, Richard C. Fuisz Garry L Myers. Process and apparatus for making rapidly dissolving dosage units and product therefrom. European Patent Office ; EP0764019A4.1995.
16. Jaybhaye A, Joshi S, Deshmukh G. Orodispersible Tablets: A Comprehensive Review. Research Journal of Pharmacy and Technology.2014; 7(3): 368-375.
17. Sahu SK, Ajazuddin, Banjare T, Gupta S, Bhandarkar A, Sahu H, Diwedi SD, Sahu P, Agrawal P, Pooja Yadav, Bhatt A, Sahu K, Dewangan D, Thapa H, Deepika, Sahu G, Sharma M, Tripathi DK, Alexander A. Formulation and evaluation of orodispersible tablet of montelukast sodium. Research Journal of Pharmacy and Technology.2018; 11(3): 1112-1118.
18. Gorle AP, Rajput RB. 2016. Formulation and evaluation of tatse mask orally dispersible paracetamol tablet. Journal of Drug Delivery and Therapeutics. 2016;6 (2):30–36.
19. Sheshala R, Khan N, Chitneni M, Darwis Y. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants. Archieves of Pharmacal. Research. 2011; 34 (11):1945–1956.
20. Chowhan Z. Moisture, hardness, disintegration and dissolution interrelationships in compressed tablets prepared by the wet granulation process. Drug Development and Industrial Pharmacy.1979; 5 (1): 41–62.
21. Iqbal Z, Babar A, Ashraf M.Controlled release naproxen using micronized ethyl cellulose by wet granulation and solid dispersion method. Drug Development and Industrial Pharmacy.2002;28 (2) :129–134.
22. Mandal S, Basu SK., Sa B. Sustained release of a water-soluble drug from alginate matrix tablets prepared by wet granulation method. AAPS PharmSciTech. 2009;10 (4):1348-1356.
23. Devi NKD, Rani AP, Madhavi BR, Mrudula BS, Swetha A. Formulation and Optimization of Orodispersible Tablets of Olanzapine. Research Journal of Pharmacy and Technology.2010; 3 (2): 543-546.
24. Srinivasa DS, Narayana Charyulu R, Satyanarayana DS, Srilakshmi D. Formulation and in vitro comparative evaluation of orodispersible tablets of Pantoprazole. Research Journal of Pharmacy and Technology.2015; 8(10): 1389-1393.
25. Deshmukh H, Chandrashekhara S., C. Nagesh, Patil M, Majethiya V. Comparative Evaluation of Disintegrant in Orodispersible Tablet of Aceclofenac. Research Journal of Pharmacy and Technology.2012; 5(6): 775-779.
26. Patel BP, Patel JK., Rajput GC,Thakor RS. Formulation and evaluation of mouth dissolving tablets of cinnarizine. Indian Journal of Pharmaceutical Sciences.2010; 72 (4): 522–525.
27. Krishnaraj K., Chandrasekar MJ, Nanjan MJ, Muralidharan S, Manikandan D. Development of sustained release antipsychotic tablets using novel polysaccharide isolated from Delonix regia seeds and its pharmacokinetic studies. Saudi Pharmaceutical Journal. 2012; 20 (3):239-248.
28. Sarfraz R, Khan H, Mahmood A, Ahmad M, Maheen S, Sher M. Formulation and evaluation of mouth disintegrating tablets of atenolol and atorvastatin. Indian Journal of Pharmaceutical Sciences. 2015;77 (1): 83-90.
29. Mohire NC, Yadav AV, Gaikwad VK. Novel Approaches in Development of Metronidazole Orodispersible Tablets. Research Journal of Pharmacy and Technology.2009; 2(2): 283-286.
30. Asha D, Jeganath S, UVNV Arjun, Sathesh Kumar S.Design and Characterization of Levofloxacin Orodispersible Tablets. Research Journal of Pharmacy and Technology.2018; 11(4): 1467-1474.
31. Anroop BN, Shery J. A simple practice guide for dose conversion between animals and human. Journal of Basic and Clinical Pharmacy. 2016;7:27-31.
32. Kim YIl, Fluckiger L, Hoffman M, Lartaud-Idjouadiene I, Atkinson J, Maincen P. The antihypertensive effect of orally administered nifedipine-loaded nanoparticles in spontaneously hypertensive rats. British. Journal of Pharmacolgy. 1997; 120 (3): 399–404.
33. Wiederhold NP. Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections.Clinical Pharmacology:Advances and Applications. 2016; 8:1-8.
34. Huang M, Chen J, Hu X, Liu J, Wu G, Zhou H, Zhu MX, Wu L, ShenTu J. Comparative bioavailability and pharmacokinetics of sirolimus tablets in healthy Chinese volunteers. Intenational Journal of Clinical Pharmacology Therapy and Toxicology. 2013;51 (10): 816–822.
35. Raoof AA, Chiu P, Ramtoola Z, Cumming IK., Teng C, Weinbach SP, Hardee GE, Levin AA, Geary RS. Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate. Journal of Pharmaceutical Sciences. 2004;93 (6):1431–1439.
36. Saravanakumar M, Raja B. Veratric acid, a phenolic acid attenuates blood pressure and oxidative stress in L-NAME induced hypertensive rats. European Journal of Pharmacology. 2011; 671 (1-3): 87–94.
37. Sung JH, Jo YS, Kim SJ, Ryu JS, Kim MC, Ko HJ, Sim SS. Effect of lutein on L-NAME-induced hypertensive rats. Korean Journal of Physiology and Pharmacology. 2013; 17 (4) :339–345.
38. Patil GB, Patil ND, Deshmukh PK, Patil PO, Bari SB. Nanostructured lipid carriers as a potential vehicle for Carvedilol delivery: Application of factorial design approach. Artificial cells, Nanomedicine and Biotechnology. 2016; 44 (1): 12–19.
39. Brus, J., Brus, ©, 2005. UNESCO/IUPAC Course NMR Spectroscopy of Polymers.
40. Shah RB, Tawakkul MA, Khan MA. Comparative evaluation of flow for pharmaceutical powders and granules. AAPS PharmSciTech. 2008; 9 (1): 250–258.
41. Sareen S, Joseph L, Mathew G. Improvement in solubility of poor water-soluble drugs by solid dispersion. International Journal of Pharmaceutical Investigation.2012;2(1):12-17.
42. Abbasi S, Yousefi G, Ansari AA, Mohammadi-Samani S. Formulation and in vitro evaluation of a fast-disintegrating/ sustained dual release bucoadhesive bilayer tablet of captopril for treatment of hypertension crises. Research in Pharmaceutical Sciences.2016; 11(4): 274–283.
43. Fuhr U, Beckmann-Knopp S, Jetter A, Lück H, Mengs U. The effect of silymarin on oral nifedipine pharmacokinetics. Planta Medica.2007; 73 (14): 1429–1435.